1 Departments of Pediatric Gastroenterology and 2 Clinical Chemistry and Pediatrics, VU University Medical Center, 1007 MB Amsterdam; 4 Laboratory for Metabolic Diseases, University Children's Hospital, 3508 AB Utrecht; and 5 Laboratory for Metabolic Diseases, Department of Pediatrics, University Hospital Groningen, 9700 RB Groningen, The Netherlands; and 3 Robert Schwartz, M.D., Center for Metabolism and Nutrition, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio 44109
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
We studied the role of lactate in
gluconeogenesis (GNG) during exercise in untrained fasting humans.
During the final hour of a 4-h cycle exercise at 33-34% maximal
O2 uptake, seven subjects received, in random order, either
a sodium lactate infusion (60 µmol · kg1 · min
1)
or an isomolar sodium bicarbonate infusion. The contribution of lactate
to gluconeogenic glucose was quantified by measuring 2H
incorporation into glucose after body water was labeled with deuterium
oxide, and glucose rate of appearance (Ra) was measured by
[6,6-2H2]glucose dilution. Infusion of
lactate increased lactate concentration to 4.4 ± 0.6 mM
(mean ± SE). Exercise induced a decrease in blood glucose
concentration from 5.0 ± 0.2 to 4.2 ± 0.3 mM
(P < 0.05); lactate infusion abolished this decrease
(5.0 ± 0.3 mM; P < 0.001) and increased glucose
Ra compared with bicarbonate infusion (P < 0.05). Lactate infusion increased both GNG from lactate (29 ± 4 to 46 ± 4% of glucose Ra, P < 0.001) and total GNG. We conclude that lactate infusion during
low-intensity exercise in fasting humans 1) increased GNG
from lactate and 2) increased glucose production, thus
increasing the blood glucose concentration. These results indicate that
GNG capacity is available in humans after an overnight fast and can be
used to sustain blood glucose levels during low-intensity exercise when
lactate, a known precursor of GNG, is available at elevated plasma levels.
lactate; hyperlactatemia; stable isotopes
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
GLUCONEOGENESIS
(GNG) is regulated by hormones (such as glucagon and insulin) and
requires three-carbon substrates, i.e., pyruvate (from lactate and
alanine) or glycerol. The relationship among substrate availability,
the rate of GNG, and the concentration of the product, glucose, in the
blood is not yet fully understood. Increased lactate concentration in
blood is known to occur in a number of metabolic disorders, e.g.,
respiratory chain disorders, pyruvate dehydrogenase deficiency, and
diabetes mellitus (13). The role of GNG under the
condition of increased substrate availability in these disorders is of
pathophysiological interest. In patients with a respiratory chain
disorder, plasma lactate concentrations are substantially increased at
low-intensity levels of exercise (35, 36); in patients
with mitochondrial myopathy due to complex I deficiency, we observed
steady-state plasma lactate concentrations of between 4 and 7 mM during
prolonged low-intensity cycle exercise at 15% of their maximal
workload (Wmax). Their mean lactate rate of appearance
(Ra) was 73 ± 12 µmol · kg1 · min
1
during exercise, which was more than double their resting lactate Ra (35, 36). In another low-intensity exercise
study in mitochondrial myopathy patients with complex I deficiency
during fasting, plasma lactate concentrations increased from 1 mM at
rest to ~4 mM during exercise and were associated with an increased
fractional contribution of lactate to glucose production as well as
increased rates of glucose production (37).
In healthy human subjects in the resting condition, increased
availability of gluconeogenic precursors does not result in an
increased rate of glucose Ra (1, 8, 14, 16, 17, 30,
41, 43) but does cause an increase in the fractional contribution of total GNG (fracGNGTOT) to glucose
Ra. These observations suggest that, at rest, the increase
in the Ra of glucose via GNG in the circulation is matched
by a decrease in the contribution of glycogenolysis. However, it is
also possible that an increase in GNG from one particular three-carbon
precursor suppresses GNG from other three-carbon precursors
(14). During exercise, whole body glucose consumption and
hepatic glucose production have both been shown to be elevated,
suggesting that additional demand is introduced on gluconeogenic
precursors (5, 9-11, 42). Glycogen is a major source
of glucose after overnight fasting (22), and glycogenolysis increases during exercise and overnight fasting (49). Whether increased availability of other
gluconeogenic precursors would increase the fractional and absolute
rates of GNG and the glucose Ra in healthy humans during
exercise and fasting is not known. From our findings in mitochondrial
myopathy patients, we hypothesized that increased lactate availability
increases GNG from pyruvate and glucose Ra in healthy
humans. To observe this effect of increased precursor availability on
GNG from pyruvate during the condition of additional demand posed by
exercise, no exogenous carbohydrate, protein, or energy should be
provided. We therefore chose to study human subjects after overnight
fasting. In healthy humans, the plasma concentration of lactate is not substantially elevated over a wide range of submaximal exercise levels,
however, and the plasma lactate level rises to values above 1 mM only
at exercise levels exceeding 65% of maximal oxygen consumption
(O2 max) (3, 23).
Untrained volunteers are able to endure levels of exercise that induce
lactate concentrations of ~4 mM (as observed in patients with
respiratory chain disorders at very low levels of exercise) only during
short periods of time (6, 34).
In view of these considerations, we studied the effect of lactate on
the rate of GNG in fasting healthy humans when lactate concentrations
were increased to a similar extent to that observed in exercising
patients with a respiratory chain disorder. Preliminary experiments
showed that low-intensity exercise decreased the fractional GNG from
pyruvate (25) and that continuous intravenous infusion of
sodium lactate at 60 µmol · kg1 · min
1
for 1 h during low-intensity cycle exercise at 15-20%
Wmax resulted in the desired steady-state hyperlactatemia
(Roef MJ and de Meer K, unpublished observations). Volunteers thus
received an external infusion of lactate during the last hour of a 4-h
low-intensity exercise protocol. This experimental model enabled us to
study the role of substrate use, GNG, and glucose Ra
before and during hyperlactatemia in healthy subjects from the context
of normal physiology. The aim of this study in exercising healthy
subjects during fasting was to answer the following questions:
1) does infusion of lactate during hyperlactatemia induce an
increase in the rate of GNG; and 2) does infusion of lactate
result in an increased glucose Ra?
In the study design, measurements of whole body glucose production and separate measurements of GNG from pyruvate and total GNG were performed, the difference representing the contribution of glycerol. Calculations were made of glucose Ra from isotope dilution with [6,6-2H2]glucose and of the fractional contributions from both pyruvate and glycerol to total GNG by use of labeling of body water with deuterium oxide and quantifying the appearance of 2H in blood glucose at carbon positions C-5 and C-6 (18, 19, 22).
![]() |
METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Subjects. Seven healthy active volunteers (3 male and 4 female), aged 21-28 yr, volunteered for the study. They regularly engaged in sport activities (range: 1-3 h/wk), but none of the subjects was performing or had been performing athletic training. None of the subjects had a family history of diabetes mellitus or was taking any medications. Written informed consent was obtained from each subject. The experimental protocol was approved by the Medical Ethics Committee of the University Children's Hospital in Utrecht.
Preexperiment testing.
All participants reported to the laboratory 3 days before the
experiments to perform an incremental maximal exercise test on an
electrically braked cycle ergometer (Lode Instruments, Groningen, The
Netherlands). Wmax and
O2 max were assessed as previously described (12). The results of this test were used to
calculate a workload of 18% Wmax as was used in the study.
The physical characteristics are listed in Table
1.
|
Experimental protocol.
Subjects reported to the laboratory at 0730 on two occasions separated
by 6 wk. A sodium lactate or sodium bicarbonate infusion study was
performed and assigned in random order. All subjects participated in
both studies. Female subjects were studied during the second half
(luteal phase) of their menstrual cycle. Four days before each study,
the subjects were placed on a diet containing
200 g of carbohydrate
daily. The subjects ate their last meals at 1800 the evening before the
day of the study. For measurement of GNG, they were given oral
2H2O (>99% 2H; Isotec,
Miamisburg, OH) and 5 g/kg body water divided into four doses (at 2100, 2200, 2300, and 2400). Body water was estimated to be 73% of fat-free
mass, which was assessed by skinfold measurements. One indwelling
catheter was inserted into a cubital vein for infusion. Another
catheter was inserted into a dorsal hand vein of the contralateral arm
for blood sampling; this hand was kept warm in a heated box to achieve
arterialization of the venous blood (21). After the blood
sample was drawn, the catheter was flushed with heparinized saline (2.5 U/ml). Subjects were acclimatized to room conditions for 30 min in the
supine position. At 0800, a basal blood sample was obtained
(time
60 min), and subsequently a primed constant-rate infusion of [6,6-2H2]glucose (98% enriched;
MassTrace, Woburn, MA) was commenced (and continued for 5 h; prime
15 µmol/kg; continuous 0.15 µmol · kg
1 · min
1).
Subjects rested in the supine position for 1 h. The study started at 0900 (time 0, i.e., 15 h after the last meal), when
they were seated on an electronically braked cycle ergometer (Lode
Instruments) and performed stationary cycle exercise at 18%
Wmax for 4 h (0-240 min). To measure oxygen
consumption, open-circuit indirect calorimetry was performed using a
face mask before (0-60 min) and during (180-240 min) the infusion.
Interventions.
To mimic changes in osmolar and acid-base balance associated with
sodium lactate infusion (17), a bicarbonate infusion was performed in each subject as a control experiment. In lactate experiments, a primed constant-rate infusion of 1 M sodium
L(+)-lactate [11.1%, wt/vol, purity 93%
L(+)-lactate; ICN Biomedicals, Zoetermeer, The
Netherlands] was started after 3 h of cycle exercise (180 min)
and continued for 60 min (prime 675 µmol/kg for 5 min; continuous 60 µmol · kg1 · min
1).
In control experiments, 1 M sodium bicarbonate (8.4%, wt/vol; prime
675 µmol bicarbonate/kg for 5 min; continuous 60 µmol · kg
1 · min
1)
was infused during the same time interval. In none of the experiments did the infused volume exceed 250 ml.
Blood sampling and urine collection.
Blood samples were drawn at regular intervals. Glucose and lactate were
measured every 30 min at rest and during the first 3 h of exercise
and then at 10-min intervals during the lactate/bicarbonate infusion.
Pyruvate and glycerol were measured every 60 min before the infusion
and every 20 min during infusion. Alanine, triglycerides, free fatty
acids, -hydroxybutyrate, acetoacetate, insulin, cortisol, and blood
gasses were measured at baseline (time 0),
preinfusion (180 min), and at the end of the infusion (240 min). The
samples were placed on ice and transferred into sodium
fluoride-containing tubes for measurement of plasma glucose, lactate,
and triglyceride or into lithium-heparin-containing tubes for
measurement of free fatty acid, glycerol, alanine, insulin, and
cortisol or into heparin-containing syringes for blood gas analysis.
Whole blood was deproteinized for measurement of blood pyruvate,
-hydroxybutyrate, and acetoacetate. Blood samples for determination
of 2H enrichments were immediately deproteinized with
Ba(OH)2 and ZnSO4, centrifuged at 4°C (1,000 g, 10 min), and stored at
70°C. Urine was voided at
time 0 and at 240 min and was collected for measurement of 2H enrichment in body water.
Sample analysis.
Plasma glucose, lactate, and triglyceride concentrations were measured
enzymatically with autoanalyzers (Dimension AR and ACA SX,
respectively; Dade). Blood gas analysis was performed on a standard
blood gas analyzer (Ciba Corning 278, Hanover, Germany). The
concentrations of [6,6-2H2]glucose used for
the tracer infusions were measured with the autoanalyzer with
calibration curves from weighted, water-free glucose (Merck, Darmstadt,
Germany). Blood pyruvate, -hydroxybutyrate, acetoacetate, plasma
free fatty acids, and glycerol were measured with automated enzymatic
colorimetric methods (COBAS FARA II; Hoffmann-La Roche,
Montpellier, France). Plasma alanine was measured by gas chromatography
(5). Plasma insulin and cortisol concentrations were
measured with a microparticle enzyme immunoassay method (IMX analyzer; Abbott, Chicago, IL) and a fluorescence polarization immunoassay (TDX analyzer; Abbott), respectively. The lowest detection limit for the insulin essay is 5 U/l.
Respiratory calorimetry.
Continuous gas analysis and volume measurements were conducted (Oxycon
Champion, Breda, The Netherlands), and standardizations were performed
as previously described (37). Oxygen consumption was
expressed as percentage of O2 max.
Calculations.
Steady-state whole body glucose Ra was calculated as
![]() |
![]() |
![]() |
![]() |
![]() |
Data analysis and statistics.
Data are presented as means ± SE unless otherwise stated. The
paired Student's t-test was used to assess the significance of differences between time points, and the unpaired t-test
was used to assess the difference between lactate and control
infusions. The Wilcoxon rank sum test was used when the data were not
normally distributed or when data for fewer than five subjects were
available. Linear regression analysis was performed to test whether the
slope of enrichment for [6,6-2H2]glucose was
significantly different from zero. Multiple analysis of variance
(MANOVA) for repeated measures was used for assessment of differences
in blood glucose concentration, GNGPYR,
fracGNGPYR, and glucose Ra. Available data
between 30 and 180 min were used to test the effect of exercise over
time, and available data between 190, 200, ... 230, and 240 min were
used to assess the effect of the intervention (lactate infusion vs.
control) and time. Statistical analyses were performed with SPSS for
Windows (version 7.5; SPSS, Chicago, IL). Statistical significance was
set at P < 0.05 (two-tailed).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Oxygen consumption during exercise.
Mean oxygen consumption during exercise in the control and lactate
experiments was 30 ± 2 and 32 ± 2%
O2 max, respectively, before the
infusions. During infusion of bicarbonate and lactate, oxygen
consumption rose to 34 ± 2 and 33 ± 2%
O2 max.
Metabolite concentrations.
In the control experiments, the mean plasma glucose levels
(Table 2 and Fig.
1A) decreased significantly
from baseline to 180 min (MANOVA, time effect P < 0.001). The preinfusion and end-of-infusion glucose
concentrations (4.5 ± 0.2 and 4.2 ± 0.3 mM, respectively) were significantly lower than the baseline value (5.0 ± 0.2 mM, both P < 0.05). Before the lactate infusions, the
glucose levels (Fig. 1A) decreased also from baseline
(MANOVA, time effect P < 0.001). Lactate infusion
resulted in a significant increase in plasma glucose level from
4.4 ± 0.2 (180 min, preinfusion) to 5.0 ± 0.3 mM (end of
infusion, P < 0.05). Plasma glucose levels were
significantly higher during lactate infusion than during bicarbonate
infusion [MANOVA, intervention effect P < 0.001, time effect not significant (NS)]. Lactate infusion significantly increased plasma lactate levels to 4.4 ± 0.6 mM (Fig. 1B;
P < 0.01); significant increases in blood pyruvate
(P < 0.05) and lactate-to-pyruvate ratio
(P < 0.01) were also present. In the control
experiments, lactate levels (and pyruvate levels; data not shown) did
not increase significantly during the final hour of exercise (Fig.
1B). Blood pH, bicarbonate, and base excess were
significantly increased during both infusions (P < 0.01). Alanine concentrations did not show major changes, but glycerol
and free fatty acid concentrations increased (4- to 6-fold) during
exercise compared with basal values under both infusion conditions.
Plasma -hydroxybutyrate and acetoacetate concentrations also
increased during exercise and showed significant differences before
infusion (lactate vs. bicarbonate at 180 min, P < 0.05) but not at the end of the infusions. Plasma insulin and cortisol
concentrations were similar before and after both infusion studies.
|
|
Fractional GNG.
Isotopic enrichments (M+1) on C-6 of glucose over time,
resulting from GNG from pyruvate before and during the experiment, are
depicted in Fig. 2A (see also
Tables 3 and 4). FracGNGPYR decreased
significantly during the first 3 h
of exercise (preinfusion vs. baseline, P < 0.05).
FracGNGPYR did not change
during bicarbonate infusion, but lactate infusion significantly
increased fracGNGPYR (from 29 ± 4 to 46 ± 4%;
MANOVA, intervention effect P < 0.001, time effect
NS). Data on total GNG during exercise were available from three
control and four lactate experiments. In these experiments, fracGNGTOT remained unchanged during the first 3 h of
exercise (preinfusion 39%) and during bicarbonate infusion
(46%; range 42-52%). Lactate infusion significantly increased
fracGNGTOT [from 45 (range: 36-63%) to 64%
(63-64%), preinfusion vs. end of infusion, respectively:
P < 0.05, lactate vs. control infusion at 240 min: P < 0.05]. The difference between
fracGNGTOT and fracGNGPYR, i.e., the fractional
contribution of glycerol to glucose Ra, did not change
during lactate infusion.
|
|
|
Glucose kinetics and absolute rate of GNG from pyruvate.
Isotopic enrichments (M+2) on C-6 of glucose over time,
resulting from [6,6-2H2]glucose dilution at
baseline and during the exercise and interventions, are depicted in
Fig. 2B (see also Table 5).
Exercise increased glucose Ra substantially. In the control
experiments, glucose Ra reached a plateau during the final
hour of exercise, and GNGPYR remained unchanged (5.1 µmol · kg1 · min
1
both at 240 min). During lactate infusion, glucose Ra
increased significantly compared with the control infusion (MANOVA,
intervention effect P < 0.05, time effect NS), and
GNGPYR increased from 5.1 ± 0.4 to 8.8 ± 0.4 µmol · kg
1 · min
1
(preinfusion vs. end of infusion, respectively, P < 0.001; lactate vs. control infusion: MANOVA, P < 0.001).
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The present study shows that, in humans performing prolonged exercise at low intensity after an overnight fast, blood glucose concentration decreased and that lactate infusion at a rate that induced hyperlactatemia ("lactate clamp") 1) abolished the decrease in blood glucose concentration, 2) increased the whole body glucose Ra, and 3) increased the fractional contribution of GNG from pyruvate to whole body glucose production.
The deuterium oxide method was used for the quantitative assessment of GNG in this study. This method uses the incorporation of 2H into glucose at carbon positions C-5 and C-6 to measure the relative contribution from pyruvate to GNGTOT (18, 19, 22). The absolute value of the contribution of GNGPYR to GNGTOT is underestimated to some extent, because exchange of 2H in labeled body water and methyl-carbon atom of pyruvate (and C-6 of glucose) is ~80% complete after fasting (24). This is due to incomplete exchange of protons at this methyl-carbon atom in the oxaloacetate pool, which is not in full equilibrium with fumarate. The effect of the exchange between fumarate and oxaloacetate depends to some degree on the relative rates of oxaloacetate-fumarate interconversion and tricarboxylic acid (TCA) cycle activity in the liver during exercise. Whether oxygen consumption and TCA cycle activity in the liver are changed during low-intensity exercise or lactate infusion is not known. During intense exercise, hepatosplanchnic uptake of oxygen has been reported to be 66% increased over resting values (31). In our study subjects, the conversion of pyruvate to phosphoenolpyruvate via oxaloacetate (i.e., GNGPYR) was 20% increased over baseline values during exercise under both study conditions and increased with 72% over preinfusion values during lactate infusion. With these considerations, we do not expect the underestimation of fracGNGPYR and GNGPYR under the conditions of our study protocol to be much different from ~20%. Other isotope methods, such as studies using carbon-labeled lactate or other carbon-labeled gluconeogenic precursors that enter via pyruvate, also result in an underestimation of fracGNGPYR caused by additional dilution of the labeled carbon atom by hepatic oxaloacetate and require a number of assumptions to correct for this additional dilution (21, 22).
In our study, plasma ketone body concentrations at 180 min were higher in experiments in which lactate was subsequently infused than in those in which bicarbonate was infused, but at rest and at the end of the infusion period no difference was found. From a study by Kalhan et al. (18), one can deduce that a pronounced increase in GNG from pyruvate could be expected in view of the preinfusion increase of plasma ketone bodies. The preinfusion difference in ketone body concentration in our study subjects was not associated with a significant difference in fractional and absolute GNG from pyruvate at the preinfusion time point. Only a minor, nonsignificant increase was observed in fractional and absolute GNG from pyruvate. Accordingly, we do not think that this preinfusion difference in plasma ketone body concentration will affect our interpretation of the data.
We observed a significant decrease of blood glucose concentration
during exercise from 5.0 to 4.2 mM after 4 h. A decrease of
similar extent has been reported by others, albeit in humans performing
exercise at higher-intensity levels, up to 65%
O2 max (15, 28, 29, 44,
45). In those studies, subjects were studied 7.5 h after
their last meal, and exercise commenced 12 h following completion
of their evening meal. In our study, exercise started 15 h after
the last meal, thus after an overnight fast. The observed decrease from
baseline glucose levels in our study subjects occurred despite an
increase in glucose Ra (60% increase over resting values)
and indicates that the rate of disappearance of glucose during exercise
at 30-35%
O2 max is even higher than the Ra.
Hyperlactatemia induced by lactate infusion increased the absolute rate
of GNG from pyruvate and glucose Ra in our study subjects. The latter finding is in contrast to several studies in humans and
other mammalian species studied at rest (1, 8, 14, 16, 17, 41,
43), which showed that infusion of gluconeogenic precursors did
not result in an increased glucose Ra. Infusion rates in
those studies were much smaller (e.g., for glycerol or alanine
between 6 and 15 µmol · kg1 · min
1)
compared with our study protocol (60 µmol
lactate · kg
1 · min
1).
The increase in GNGPYR in our study, from 5 to 8.8 µmol
glucose · kg
1 · min
1,
is equivalent to a disposal of 7.6 (i.e., 2 × 3.8) µmol
lactate · kg
1 · min
1,
representing ~13% of the disposal of the infused lactate. It is possible that a potential increase in GNG from precursor infusion was not measured with sufficient power in previous studies, which used
infusion rates 4-10 times lower than the infusion rate that we
chose, assuming an equivalent proportional increase in GNG at such
lower rates. Differences in physiological state could also explain the
difference between our findings (obtained during prolonged
low-intensity exercise) and those of previous studies (obtained in
subjects under resting conditions). Recently, Miller and colleagues
(28, 29) studied the effect of hyperlactatemia due to
lactate infusion (lactate clamp) in healthy volunteers at rest and
under exercise at moderate and high intensity. In contrast to our
observations, they found a decrease in glucose Ra during
lactate infusion under exercise. According to those authors, lactate
inhibited peripheral glucose utilization and prevented a decrease in
blood glucose concentration and thereby the necessity for the liver to
increase glucose production. The contrasting findings in the rate of
GNGPYR and glucose Ra of human volunteers
during similar levels of induced hyperlactatemia but performing
different levels of exercise (low-intensity exercise in our study and
moderate-to-intense exercise in the studies of Miller and colleagues)
might be explained by differences in preferential use of lactate over
glucose by working muscle and associated differential sparing of blood
glucose and autoregulation by the liver to increase glucose output (see
below). However, other explanations are also possible. It might
be that exercise at higher levels than those used in our study
reapportioned cardiac output preferentially to working muscles
and thereby limited substrate supply to the liver. Differences in
hormonal responses to exercise at different levels could also be
involved. In our study, insulin levels remained low, and cortisol
concentrations were unchanged during the lactate and control infusions.
This suggests that the increased availability of lactate resulted in an
increase in glucose output in the lower range of euglycemia without
much change in the hormonal regulation in our fasting human volunteers.
The increased rate of hepatic glucose production during lactate infusion was accompanied by an increased fracGNGTOT of 19% (from 45 to 64% in 4 subjects) and by an increased fracGNGPYR of 17% (from 29 to 46% in 7 subjects). In control experiments, no such changes were observed in the same subjects. Previous studies did not quantify the contribution of GNGPYR to GNGTOT. Our findings suggest for the first time that increased availability of lactate as a precursor, although it increased GNGPYR under the condition of decreased blood glucose concentration during low-intensity exercise, did not change the GNG from glycerol in fasting exercising adult volunteers. The mean value for GNGTOT during hyperlactatemia may be representative of the change in the rate of GNGTOT during exercise and hyperlactatemia in the human population, but caution should be used due to the limited number of subjects in our study.
Our data indicate that GNG represents a minor (~13% of the load; see above) contribution to lactate disposal under the conditions studied here. Lactate oxidation and muscle glyconeogenesis are also metabolic fates of excess lactate in healthy humans. Glyconeogenesis can remove excess circulating lactate and has been demonstrated in resting skeletal muscle in rodents (25, 27, 32). In perfused, noncontracting rat hindlimb, McLane and Holloszy (27) found a proportional increase in muscle glycogen synthesis during induced hyperlactatemia between 4 and 25 mM. However, estimations of the relative contribution of lactate to muscle glyconeogenesis in the literature vary widely, and data in humans performing submaximal exercise are not available (25). Oxidation is an important mechanism for disposal of lactate during exercise and has been demonstrated in skeletal muscle in humans during and after work (6, 9, 24, 48). Our study focused on quantification of GNG to remove lactate and on glucose Ra, and the contributions of glyconeogenesis and oxidation to lactate removal were not measured separately.
Regulation of the gluconeogenic contribution to glucose synthesis
resides in part in (re)partitioning of hepatic glucose 6-phosphate between hepatic glycogen synthesis and hepatic glucose production (2, 47). Excess gluconeogenic glucose 6-phosphate (e.g., during GNG precursor infusion in resting humans) will most likely be
repartitioned into glycogen synthesis to avoid hyperglycemia. This
combination, of a continuous de novo synthesis of glucose 6-phosphate
from an infused substrate with subsequent partitioning of newly
synthesized glucose 6-phosphate depending on blood glucose concentrations, offers a way of acute regulation of hepatic glucose production independent of hormonal changes. This provides the mechanism
for the liver to respond directly to changes in blood glucose with
changes in hepatic glucose production, a phenomenon known as hepatic
autoregulation (30). Recently, Coker et al. (7) demonstrated in dogs that moderate excercise in the
absence of changes in circulating hormone concentrations resulted in a moderate decrease of blood glucose concentrations accompanied by
increased hepatic glucose production. It appears that this autoregulation of glucose production in the liver is a way to keep
blood glucose at low physiological concentrations during exercise and
thereby prevent hypoglycemia from occurring. Our data showing increased
GNGPYR and glucose Ra in fasting human volunteers during low-intensity exercise and hyperlactatemia are in
agreement with this explanation. Jenkins et al. (15) have previously shown in fasting humans that glucose production during exercise at 55% O2 max was subject to
feedback control by circulating glucose within the range of
5.1-5.4 mM, with insulin levels (studied during control and
insulin infusions) inversely related to glucose Ra.
Although our data were obtained in humans at lower exercise conditions
(30-35%
O2 max) than those of
Jenkins et al., the glucose concentrations (range 4.2-5.0 mM) and
low insulin levels in our subjects suggest that sensitivity of glucose
production to circulating glucose levels was present. There are no data
on the partitioning of hepatic glucose 6-phosphate between blood
glucose and glycogen synthesis under the conditions of our experimental
protocol, and the net effect of hepatic glycogen synthesis and
glycogenolysis during lactate infusion thus cannot be estimated with
our present data.
Our study results have potential implications for the understanding of
human health and disease. We used the same experimental protocol to
measure GNG during prolonged low-intensity exercise in patients with a
respiratory chain disorder (mitochondrial myopathy due to complex I
deficiency). During fasting, the mean resting plasma lactate
concentration in these patients was 1.1 ± 0.1 mM, and the rate of
GNGPYR was 4.5 ± 1.4 µmol · kg1 · min
1.
During cycle exercise at 15% of their Wmax, their lactate
levels rose to 4.0 ± 1.0 mM, and GNGPYR increased to
7.4 ± 1.9 µmol · kg
1 · min
1
(37). These results compare favorably with our data in
healthy volunteers at rest and exercising at 18% of Wmax
during induced hyperlactatemia (4.6 ± 0.6 mM). The combined data
suggest that patients with a respiratory chain defect in the
mitochondria of their skeletal muscles exhibit a normal gluconeogenic
response to increases in circulating lactate concentrations during
low-intensity exercise. The present study demonstrates that this
response is also present in healthy humans exercising at similar
relative levels of low-intensity exercise during induced
hyperlactatemia and underpins the central role of lactate as an
intermediate linking glycolysis, GNG, and the TCA cycle.
We conclude that healthy humans under conditions of induced hyperlactatemia during prolonged low-intensity exercise increase lactate disposal via GNG, increase whole body glucose production, and sustain the blood glucose concentration. Our results indicate that GNG capacity is available in untrained active humans after an overnight fast and can be used to sustain blood glucose levels during low-intensity exercise when lactate, a known precursor of GNG, is available at elevated plasma levels.
![]() |
ACKNOWLEDGEMENTS |
---|
This work was supported by grants from the Netherlands Organization for Scientific Research and the Foundation "De Drie Lichten" in the Netherlands, and a grant from the National Institutes of Health (RR-00080) Core Mass Spectrometry Laboratory.
![]() |
FOOTNOTES |
---|
Address for reprint requests and other correspondence: K. de Meer, Dept. of Clinical Chemistry, VU University Medical Center, Reception K, PO Box 7507, 1007 MB Amsterdam, The Netherlands (E-mail: novosilski{at}hotmail.com).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published February 25, 2003;10.1152/ajpendo.00425.2002
Received 2 October 2002; accepted in final form 13 February 2003.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1.
Ahlborg, G,
Felig P,
Hagenfeldt L,
Hendler R,
and
Wahren J.
Substrate turnover during prolonged exercise in man.
J Clin Invest
53:
1080-1090,
1974[ISI][Medline].
2.
Aiston, S,
Trinh KY,
Lange AJ,
Newgard CD,
and
Agius L.
Glucose-6-phosphatase overexpression lowers glucose 6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation. Evidence against feedback inhibition of glucokinase.
J Biol Chem
274:
24559-24566,
1999
3.
Astorino, TA.
Is the ventilatory threshold coincident with maximal fat oxidation during submaximal exercise?
J Sports Med Phys Fitness
40:
209-216,
2000[ISI][Medline].
4.
Battezzati, A,
Haisch M,
Brillon DJ,
and
Matthews DE.
Splanchnic utilization of enteral alanine in humans.
Metabolism
48:
915-921,
1999[ISI][Medline].
5.
Bergman, BC,
Horning MA,
Casazza GA,
Wolfel EE,
Butterfield GE,
and
Brooks GA.
Endurance training increases gluconeogenesis during rest and exercise in men.
Am J Physiol Endocrinol Metab
278:
E244-E251,
2000
6.
Brooks, GA,
and
Gaesser GA.
End point of lactate and glucose metabolism after exhausting exercise.
J Appl Physiol
49:
1057-1069,
1980
7.
Coker, RH,
Koyama Y,
Denny JC,
Camacho RC,
Lacy DB,
and
Wasserman DH.
Prevention of overt hypoglycemia during exercise. Stimulation of endogenous glucose production independent of hepatic catecholamine action and changes in pancreatic hormone concentration.
Diabetes
51:
1310-1318,
2002
8.
Connolly, CC,
Stevenson RW,
Neal DW,
Wasserman DH,
and
Cherrington AD.
The effects of lactate loading on alanine and glucose metabolism in the conscious dog.
Metabolism
42:
154-161,
1993[ISI][Medline].
9.
Donovan, CM,
and
Brooks GA.
Endurance training affects lactate clearance, not lactate production.
Am J Physiol Endocrinol Metab
244:
E83-E92,
1983
10.
Donovan, CM,
and
Pagliassotti MJ.
Endurance training enhances lactate clearance during hyperlactatemia.
Am J Physiol Endocrinol Metab
257:
E782-E789,
1989
11.
Donovan, CM,
and
Sumida KD.
Training improves glucose homeostasis in rats during exercise via glucose production.
Am J Physiol Regul Integr Comp Physiol
258:
R770-R776,
1990
12.
Gulmans, VAM,
De Meer K,
Brackel HJL,
and
Helders PJM
Maximal work capacity in relation to nutritional status in children with cystic fibrosis.
Eur Respir J
10:
2014-2017,
1997
13.
Israels, S,
Haworth JC,
Dunn HG,
and
Applegarth DA.
Lactic acidosis in childhood.
Adv Pediatr
22:
267-303,
1976[Medline].
14.
Jahoor, F,
Peters EJ,
and
Wolfe RR.
The relationship between gluconeogenic substrate supply and glucose production in humans.
Am J Physiol Endocrinol Metab
258:
E288-E296,
1990
15.
Jenkins, AB,
Furler SM,
Chisholm DJ,
and
Kraegen EW.
Regulation of hepatic glucose output during exercise by circulating glucose and insulin in humans.
Am J Physiol Regul Integr Comp Physiol
250:
R411-R417,
1986
16.
Jenssen, T,
Nurjhan N,
Consoli A,
and
Gerich JE.
Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans.
J Clin Invest
86:
489-497,
1990[ISI][Medline].
17.
Jenssen, T,
Nurjhan N,
Consoli A,
and
Gerich JE.
Dose-response effects of lactate infusions on gluconeogenesis from lactate in normal man.
Eur J Clin Invest
23:
448-454,
1993[ISI][Medline].
18.
Kalhan, S,
Rossi K,
Gruca L,
Burkett E,
and
O'Brien A.
Glucose turnover and gluconeogenesis in human pregnancy.
J Clin Invest
100:
1775-1781,
1997
19.
Kalhan, SC,
Trivedi R,
Singh S,
Chandramouli V,
Schumann WC,
and
Landau BR.
A micromethod for the measurement of deuterium bound to carbon-6 of glucose to quantify gluconeogenesis in vivo.
J Mass Spectrom
30:
1588-1592,
1995[ISI].
20.
Landau, BR.
Estimating gluconeogenic rates in NIDDM.
Adv Exp Med Biol
334:
205-220,
1992.
21.
Landau, BR,
Chandramouli V,
Schumann WC,
Ekberg K,
Kumaran K,
Kalhan SC,
and
Wahren J.
Estimates of Krebs cycle activity and contributions of gluconeogenesis to hepatic glucose production in fasting healthy subjects and IDDM patients.
Diabetologia
38:
831-838,
1995[ISI][Medline].
22.
Landau, BR,
Wahren J,
Chandramouli V,
Schumann WC,
Ekberg K,
and
Kalhan SC.
Contributions of gluconeogenesis to glucose production in the fasted state.
J Clin Invest
98:
378-385,
1996
23.
Luger, A,
Watschinger B,
Deuster P,
Scoboda T,
Clodi M,
and
Chrousos GP.
Plasma growth hormone and prolactin responses to graded levels of acute exercise and to a lactate infusion.
Neuroendocrinology
56:
112-127,
1992[ISI][Medline].
24.
Mazzeo, RS,
Brooks GA,
Schoeller DA,
and
Budinger TF.
Disposal of blood [1-13C]lactate in humans during rest and exercise.
J Appl Physiol
60:
232-241,
1986
25.
McDermott, JC,
and
Bonen A.
Glyconeogenic and oxidative lactate metabolism in skeletal muscle.
Can J Physiol Pharmacol
70:
142-149,
1992[ISI][Medline].
26.
McGuire, EAM,
Helderman JH,
Tobin JD,
Andres R,
and
Berman M.
Effects of arterial versus venous sampling on analysis of glucose kinetics in man.
J Appl Physiol
41:
565-573,
1976
27.
McLane, JA,
and
Holloszy JO.
Glycogen synthesis from lactate in the three types of skeletal muscle.
J Biol Chem
254:
6548-6553,
1979[ISI][Medline].
28.
Miller, BF,
Fattor JA,
Jacobs KA,
Horning MAS,
Navazio F,
Lindinger MI,
and
Brooks GA.
Lactate and glucose interactions during rest and exercise in men: effect of exogenous lactate infusion.
J Physiol
544:
963-975,
2002
29.
Miller, BF,
Fattor JA,
Jacobs KA,
Horning MA,
Suh S-H,
Navazio F,
and
Brooks GA.
Metabolic and cardiorespiratory responses to "the lactate clamp."
Am J Physiol Endocrinol Metab
283:
E889-E898,
2002
30.
Moore, MC,
Conolly CC,
and
Cherrington AD.
Autoregulation of hepatic glucose production.
Eur J Endocrinol
138:
240-248,
1998[ISI][Medline].
31.
Nielsen, HB,
Clemmesen JO,
Skak C,
Ott P,
and
Secher NH.
Attenuated hepatosplenic uptake of lactate during intense exercise in humans.
J Appl Physiol
92:
1677-1683,
2002
32.
Pagliosotti, MJ,
and
Donovan CM.
Glycogen from lactate in rabbit skeletal muscle fiber types.
Am J Physiol Regul Integr Comp Physiol
258:
R903-R911,
1990
33.
Previs, SF,
Hazey JW,
Diraison F,
Beylot M,
David F,
and
Brunengraber H.
Assay of the deuterium enrichment of water via acetylene.
J Mass Spectrom
31:
639-642,
1996[ISI][Medline].
34.
Richardson, S,
and
Hardman AE.
Endurance fitness and blood lactate concentration during stepping exercise in untrained subjects.
Br J Sports Med
23:
190-193,
1989[Abstract].
35.
Roef, MJ,
De Meer K,
Reijngoud D-J,
Straver HWHC,
De Barse M,
Kalhan SC,
and
Berger R.
Triacylglycerol infusion improves exercise endurance in patients with mitochondrial myopathy due to Complex I deficiency.
Am J Clin Nutr
75:
237-244,
2002
36.
Roef, MJ,
De Meer K,
Reijngoud D-J,
Straver HWHC,
De Barse M,
Kalhan SC,
and
Berger R.
Triacylglycerol infusion does not improve hyperlactatemia in resting patients with mitochondrial myopathy due to Complex I deficiency.
Am J Clin Nutr
75:
228-236,
2002
37.
Roef, MJ,
Kalhan SC,
Reijngoud D-J,
De Meer K,
and
Berger R.
Lactate disposal via gluconeogenesis is increased during exercise in patients with mitochondrial myopathy due to Complex I deficiency.
Pediatr Res
51:
592-597,
2002
38.
Schumann, WC,
Magnusson I,
Chandramouli V,
Kumaran K,
Wahren J,
and
Landau BR.
Metabolism of [2-14C]acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis.
J Biol Chem
266:
6985-6990,
1991
39.
Stanley, WC,
Wisneski JA,
Gertz EW,
Neese RA,
and
Brooks GA.
Glucose and lactate interrelations during moderate-intensity exercise in humans.
Metabolism
37:
850-858,
1988[ISI][Medline].
40.
Steele, R.
Influence of glucose loading and of injected insulin on hepatic glucose output.
Ann NY Acad Sci
82:
420-430,
1959[ISI].
41.
Steele, R,
Winkler B,
and
Altszuler N.
Inhibition by infused glycerol of gluconeogenesis from other precursors.
Am J Physiol
221:
883-888,
1971
42.
Sumida, KD,
and
Donovan CM.
Enhanced hepatic gluconeogenic capacity for selected precursurs after endurance training.
J Appl Physiol
79:
1883-1888,
1995
43.
Tounian, P,
Schneiter P,
Henry S,
Jéquier E,
and
Tappy L.
Effects of infused fructose on endogenous glucose production, gluconeogenesis, and glycogen metabolism.
Am J Physiol Endocrinol Metab
267:
E710-E717,
1994
44.
Trimmer, JK,
Casazza GA,
Horning MA,
and
Brooks GA.
Autoregulation of glucose production in men with a glycerol load during rest and exercise.
Am J Physiol Endocrinol Metab
280:
E657-E668,
2001
45.
Trimmer, JK,
Schwarz J-M,
Casazza GA,
Horning MA,
Rodriguez N,
and
Brooks GA.
Measurement of gluconeogenesis in exercising men by mass isotopomer distribution analysis.
J Appl Physiol
93:
233-241,
2002
46.
Tserng, K,
and
Kalhan SC.
Calculation of substrate turnover rate in stable isotope tracer studies.
Am J Physiol Endocrinol Metab
245:
E308-E311,
1983
47.
Van Dijk, TH,
Van der Sluijs FJ,
Wiegman CH,
Baller JFW,
Gustafson LA,
Burger H-J,
Herling AW,
Kuipers F,
Meijer AJ,
and
Reijngoud D-J.
Acute inhibition of hepatic glucose-6-phosphatase does not affect gluconeogenesis but directs gluconeogenic flux toward glycogen in fasted rats. A pharmacological study with the chlorogenic acid derivative S4048.
J Biol Chem
276:
25727-25735,
2001
48.
Van Hall, G,
Jensen-Urstad M,
Rosdahl H,
Holmberg HC,
Saltin B,
and
Calbet JAL
Leg and arm lactate and substrate kinetics during exercise.
Am J Physiol Endocrinol Metab
284:
E193-E205,
2003
49.
Wasserman, DH,
and
Cherrington AD.
Hepatic fuel metabolism during muscular work: role and regulation.
Am J Physiol Endocrinol Metab
260:
811-824,
1991.